OMENIX 20 mg is a proton pump inhibitor (PPI) containing omeprazole, manufactured by Incepta Pharmaceuticals Ltd. It is primarily used to treat acid-related gastrointestinal disorders, including gastroesophageal reflux disease (GERD), peptic ulcers, heartburn, and Zollinger-Ellison syndrome. By inhibiting the proton pump in the stomach lining, omeprazole effectively reduces gastric acid secretion, providing relief from symptoms and promoting healing of the esophagus and stomach lining. The typical dosage is 20 mg once daily, taken on an empty stomach, preferably in the morning, at least 30–60 minutes before food intake